As of November 15, 2026, CorMedix Inc. is a publicly traded company (Nasdaq: CRMD); its largest reported holder is Deep Track Capital, with 7.94% on Schedule 13G/A of May 15, 2026, then Shaibatalhamd Aymen Abdalkader (5.9%). The largest insider holding is Joseph Todisco, the chief executive and a director, with 774,749 shares (0.97% of shares outstanding), per Form 4 of February 6, 2026 (Schedule 13G/A, May 15, 2026).
Is this your company?
About to sign with, pay or invest in CorMedix Inc.? See the free Snapshot first.
Free to see. No signup.
Is CorMedix Inc. a real, registered company?
- CorMedix Inc. files with the SEC under CIK 1410098 (its SEC filings).
- Its shares are listed under the ticker CRMD on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Parsippany, New Jersey, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CorMedix Inc. in our court records and SEC 8-K records (as of 2026-11-15).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Shaibatalhamd Aymen Abdalkader (filed 2026-06-12).
Who are CorMedix Inc.'s owners and officers?
CorMedix Inc.: incorporated in Delaware; business address in Parsippany, New Jersey; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-06-12).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-06-12 | Shaibatalhamd Aymen Abdalkader | 5.9% |
| Schedule 13G/A, 2026-06-12 | Shaibatalhamd Aymen Abdalkader | 5.9% |
| Schedule 13G/A, 2026-05-15 | Deep Track Capital, LP | 7.94% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-01-02 | Shaibatalhamd Aymen Abdalkader | 5.8% |
| Schedule 13G, 2025-12-01 | Deep Track Capital, LP | 6.29% |
| Schedule 13G/A, 2025-08-08 | Shaibatalhamd Aymen Abdalkader | 6.2% |
Questions about who owns CorMedix Inc.
Who owns CorMedix Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of CorMedix Inc.: Deep Track Capital, LP (7.94%, Schedule 13G/A, filed 2026-05-15) and Shaibatalhamd Aymen Abdalkader (5.9%, Schedule 13G/A, filed 2026-06-12).
Who are the largest shareholders of CorMedix Inc.?
By the share each holder's latest filing reports, the largest holders of CorMedix Inc. on this page are Deep Track Capital, LP (7.94%) and Shaibatalhamd Aymen Abdalkader (5.9%).
When did Deep Track Capital, LP buy into CorMedix Inc.?
The filings give report dates, not purchase dates. The earliest filing from Deep Track Capital, LP on this page is the Schedule 13G, filed 2025-12-01, reporting 6.29%; its latest, Schedule 13G/A filed 2026-05-15, reports 7.94%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on CorMedix Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CorMedix Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CorMedix Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own CorMedix Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 774,749 shares (0.97% of shares outstanding) (Form 4, 2026-02-06).
- , the chief operating officer: 270,463 shares (0.34% of shares outstanding) (Form 4, 2026-09-01).
- , a director: 261,487 shares (0.33% of shares outstanding), 231,487 held directly and 30,000 indirectly (Form 4, 2026-01-27).
- , the chief legal officer: 260,684 shares (0.33% of shares outstanding) (Form 4, 2026-09-01).
- , a director: 158,103 shares (0.20% of shares outstanding), 125,951 held directly and 32,152 indirectly (Form 4, 2026-01-27).
Shares outstanding: 79,537,626 as of 2026-11-09, from the company's latest SEC cover page.
How much has CorMedix Inc. raised?
Latest IPO step: CorMedix Inc. withdrew its IPO registration (RW, 2025-10-07).
IPO filings: RW, 2025-10-07, RW, 2025-10-06.
Keep reading
More on CorMedix Inc. and the records around it.
Companies that share a holder
- Deep Track Capital, LP also filed stake reports on 60 other companies: Mentari Therapeutics, Inc. (Nov 2026), Alector, Inc. (Oct 2026), TCGX Acquisition Corp. II (Oct 2026)
- The Vanguard Group also filed stake reports on 2385 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cormedix